Showing results (211-220 of 254) with videos related to

Sort By:
Pageof 26
Journal of Hepatology|April 24, 2021
A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathySara Montagnese, Mette Lauridsen, Hendrik Vilstrup, et al.
Clinical and Molecular Hepatology|May 20, 2026
The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLDYu Shi, Ruoqi Zhou, Seung Up Kim, et al.
JAMA Network Open|November 6, 2025
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 DiabetesJeffrey V Lazarus, Leire Agirre-Garrido, Luis Antonio Díaz, et al.
The Lancet Regional Health. Europe|June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver diseaseNicola Pugliese, Trenton M White, Paul N Brennan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune HepatitisCumali Efe, Hannes Hagström, Henriette Ytting, et al.
Hepatology (Baltimore, Md.)|January 24, 2021
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus StatementHannes Hagström, Leon A Adams, Alina M Allen, et al.
Nature Reviews. Endocrinology|February 22, 2023
Consensus Statement on the definition and classification of metabolic hyperferritinaemiaLuca Valenti, Elena Corradini, Leon A Adams, et al.
The Lancet. Gastroenterology & Hepatology|December 9, 2023
Implementation of a liver health check in people with type 2 diabetesKushala W M Abeysekera, Luca Valenti, Zobair Younossi, et al.
Hepatology (Baltimore, Md.)|July 27, 2026
Implications of new obesity definitions in the classification and outcomes of patients with MASLDJie Cai, Terry Cheuk-Fung Yip, Huapeng Lin, et al.
Plos Medicine|July 23, 2014
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisGiovanni Musso, Roberto Gambino, James H Tabibian, et al.
Pageof 26